Factors affecting shared decision-making concerning menopausal hormone therapy.

Autor: Koysombat K; Section of Endocrinology and Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK.; Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK., Mukherjee A; Spire Manchester Hospital, Manchester, UK., Nyunt S; Section of Endocrinology and Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK.; Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK., Pedder H; Department of Population Health Sciences, University of Bristol, Bristol, UK., Vinogradova Y; Division of Primary Care, School of Medicine, University of Nottingham, Nottingham, UK., Burgin J; Centre for Academic Primary Care, Bristol Medical School, Bristol, UK., Dave H; Woman representative with lived-experience of menopause, London, UK., Comninos AN; Section of Endocrinology and Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK.; Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK., Talaulikar V; Reproductive Medicine Unit, University College Hospital, London, UK., Bailey JV; eHealth Unit, Department of Primary Care and Population Health, University College London, Royal Free Hospital, London, UK., Dhillo WS; Section of Endocrinology and Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK.; Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK., Abbara A; Section of Endocrinology and Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK.; Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK.
Jazyk: angličtina
Zdroj: Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2024 Aug; Vol. 1538 (1), pp. 34-44. Date of Electronic Publication: 2024 Jul 17.
DOI: 10.1111/nyas.15185
Abstrakt: Menopausal hormone therapy (MHT) is an effective treatment for menopause-related symptoms. Menopause management guidelines recommend a personalized approach to menopause care, including MHT use. Decision-making around menopause care is a complex, iterative process influenced by multiple factors framed by perspectives from both women and healthcare providers (HCPs). This narrative review aims to summarize evidence around factors affecting decision-making regarding menopause-related care. For HCPs, the provision of individualized risk estimates is challenging in practice given the number of potential benefits and risks to consider, and the complexity of the data available, especially within time-limited consultations. Women seeking menopause care have the difficult task of making sense of the benefit versus risk profiles to make choices in line with their decisional needs influenced by sociocultural/economic, educational, demographic, and personal characteristics. The press, social media, and influential celebrities also impact the perception of menopause and decision-making around it. Understanding these factors can lead to improved participation in shared decision-making, satisfaction with the decision and decision-making process, adherence to treatment, reduced decisional regret, efficient use of resources, and ultimately long-term satisfaction with care.
(© 2024 The Author(s). Annals of the New York Academy of Sciences published by Wiley Periodicals LLC on behalf of The New York Academy of Sciences.)
Databáze: MEDLINE
Externí odkaz: